Fortress Biotech (FBIO) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Powered by 
Analysis
Fortress Biotech (FBIO) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 14.05% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 11.65% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 411.50% |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -3.34% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 16.78% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 1.66% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 19.96% |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | -30.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -30.64% |
| Dec 31, 2025 | -42.16% |
| Sep 30, 2025 | -42.55% |
| Jun 30, 2025 | -42.22% |
| Mar 31, 2025 | -42.13% |
| Dec 31, 2024 | -39.96% |
| Sep 30, 2024 | -37.55% |
| Jun 30, 2024 | -35.35% |
| Mar 31, 2024 | -20.71% |
| Dec 31, 2023 | -18.29% |
| Sep 30, 2023 | -17.29% |
| Jun 30, 2023 | -16.37% |
| Mar 31, 2023 | -1.57% |
| Dec 31, 2022 | 1.55% |
| Sep 30, 2022 | 4.26% |
| Jun 30, 2022 | 5.26% |
| Mar 31, 2022 | 6.84% |
| Dec 31, 2021 | 7.82% |
| Sep 30, 2021 | -1.54% |
| Jun 30, 2021 | 73.07% |